We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BFRI market cap is 8.06M. The company's latest EPS is USD -2.5978 and P/E is -0.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 8.9M | 10.6M | 7.91M | 7.84M | 9.01M |
| Operating Income | -4.42M | -3.87M | -5.47M | -5.08M | -4.96M |
| Net Income | -6.34M | 3.53M | -10.44M | -257k | -5.67M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18.85M | 24.1M | 28.67M | 34.07M |
| Operating Income | -9.61M | -26.6M | -22.38M | -22.58M |
| Net Income | -10.99M | -37.71M | -640k | -20.13M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 34.1M | 27.93M | 24.58M | 21.57M | 18.52M |
| Total Liabilities | 33.07M | 23.14M | 26.42M | 10.66M | 12.99M |
| Total Equity | 1.04M | 4.79M | -5.42M | 10.91M | 5.53M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.14M | 53.22M | 50.88M | 27.93M |
| Total Liabilities | 18.31M | 41.88M | 27.01M | 23.14M |
| Total Equity | 5.83M | 11.34M | 23.88M | 4.79M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -16.03M | -24.9M | -3.33M | -8.05M | -9.25M |
| Investing | 546k | 619k | N/A | -2k | -2k |
| Financing | 1.7M | 8.41M | 5.8M | 11.08M | 10.79M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.37M | -26.72M | -16.2M | -24.9M |
| Investing | N/A | -11k | -5.16M | 619k |
| Financing | 13.19M | 43.19M | 14.02M | 8.41M |
| Market Cap | 8.06M |
| Price to Earnings Ratio | -0.40 |
| Price to Sales Ratio | 0.24 |
| Price to Cash Ratio | 6 |
| Price to Book Ratio | 1.68 |
| Dividend Yield | - |
| Shares Outstanding | 7.75M |
| Average Volume (1 week) | 3.84M |
| Average Volume (1 Month) | 1.1M |
| 52 Week Change | -55.17% |
| 52 Week High | 2.4302 |
| 52 Week Low | 0.61 |
| Spread (Intraday) | 0.07 (6.31%) |
| Company Name | Biofrontera Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.biofrontera-us.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
